The Valley Desk

Clinical trial reportThe British journal of dermatologyPublished

Durability of response to icotrokinra in adults with moderate-to-severe plaque psoriasis: 1-year results from the phase III, placebo- and active comparator-controlled ICONIC-ADVANCE 1 and ICONIC-ADVANCE 2 trials

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Clinical trial report
Venue
The British journal of dermatology
Published
Subject terms
Humans; Psoriasis; Dermatologic Agents; Treatment Outcome; Severity of Illness Index; Double-Blind Method; Adult; Aged; Middle Aged; Female; Male; Patient Reported Outcome Measures
PubMed ID
42397072
Added to directory
Source checked

Report a correction or request removal